123 related articles for article (PubMed ID: 22841205)
1. Serum levels of interleukin-9 during acute rejection in liver transplantation.
Fábrega E; López-Hoyos M; San Segundo D; Casafont F; Angel Mieses M; Sampedro B; Pons-Romero F
Transplant Proc; 2012; 44(6):1533-5. PubMed ID: 22841205
[TBL] [Abstract][Full Text] [Related]
2. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation.
Fábrega E; López-Hoyos M; San Segundo D; Casafont F; Pons-Romero F
Liver Transpl; 2009 Jun; 15(6):629-33. PubMed ID: 19479806
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-9 in stable liver transplant recipients.
Fábrega E; López-Hoyos M; San Segundo D; Casafont F; Moraleja I; Sampedro B; Pons-Romero F
Transplant Proc; 2012; 44(6):1536-8. PubMed ID: 22841206
[TBL] [Abstract][Full Text] [Related]
4. Value of soluble CD30 in liver transplantation.
Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
[TBL] [Abstract][Full Text] [Related]
5. Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.
Zhao Z; Yang C; Tang Q; Zhao T; Jia Y; Ma Z; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Dec; 44(10):2982-5. PubMed ID: 23195010
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.
Farid WR; Pan Q; van der Meer AJ; de Ruiter PE; Ramakrishnaiah V; de Jonge J; Kwekkeboom J; Janssen HL; Metselaar HJ; Tilanus HW; Kazemier G; van der Laan LJ
Liver Transpl; 2012 Mar; 18(3):290-7. PubMed ID: 21932376
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 production during liver allograft rejection in humans.
Conti F; Frappier J; Dharancy S; Chereau C; Houssin D; Weill B; Calmus Y
Transplantation; 2003 Jul; 76(1):210-6. PubMed ID: 12865812
[TBL] [Abstract][Full Text] [Related]
8. Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation.
San Segundo D; Ruiz P; Irure J; Arias-Loste MT; Cuadrado A; Puente A; Casafont F; López-Hoyos M; Crespo J; Fábrega E
Transplant Proc; 2016 Nov; 48(9):2977-2979. PubMed ID: 27932123
[TBL] [Abstract][Full Text] [Related]
9. CC-chemokine RANTES is increased in serum and urine in the early post-transplantation period of human renal allograft recipients.
Baer PC; Koziolek M; Fierlbeck W; Geiger H
Kidney Blood Press Res; 2005; 28(1):48-54. PubMed ID: 15509902
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of interleukin-8 in urine and in serum of patients after kidney transplantation].
Boratyńska M
Przegl Lek; 1998; 55(11):576-80. PubMed ID: 10216370
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 and kidney allograft outcome.
Crispim JC; Grespan R; Martelli-Palomino G; Rassi DM; Costa RS; Saber LT; Cunha FQ; Donadi EA
Transplant Proc; 2009 Jun; 41(5):1562-4. PubMed ID: 19545679
[TBL] [Abstract][Full Text] [Related]
12. Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?
Joo DJ; Ju MK; Huh KH; Kim MS; Choi GH; Choi JS; Jeon KO; Kim SI
Transplant Proc; 2012 Mar; 44(2):418-20. PubMed ID: 22410032
[TBL] [Abstract][Full Text] [Related]
13. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
Matinlauri I; Höckerstedt K; Isoniemi H
Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
[TBL] [Abstract][Full Text] [Related]
14. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
[TBL] [Abstract][Full Text] [Related]
15. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
Azarpira N; Aghdaie MH; Malekpour Z
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
[TBL] [Abstract][Full Text] [Related]
19. Low level of interleukin 10 synthesis during liver allograft rejection.
Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
[TBL] [Abstract][Full Text] [Related]
20. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
